European journal of obstetrics, gynecology, and reproductive biology
-
Eur. J. Obstet. Gynecol. Reprod. Biol. · Nov 2015
In search of key genes associated with endometriosis using bioinformatics approach.
The aim of this study was to identify key genes associated with endometriosis. ⋯ Our findings indicate that EGF, IL-1β and AGTR1 may play important roles in the pathogenesis of endometriosis.
-
Eur. J. Obstet. Gynecol. Reprod. Biol. · Nov 2015
Postpartum care of women with gestational diabetes: survey of healthcare professionals.
To assess the knowledge and practices of healthcare professionals on the postpartum care of women with gestational diabetes. ⋯ The survey highlights the need for improved awareness of future risk of diabetes in women with gestational diabetes, consensus on optimal postpartum screening and identification of the main healthcare provider responsible for further management. This is particularly important for areas of social deprivation.
-
Eur. J. Obstet. Gynecol. Reprod. Biol. · Nov 2015
Determination of the 90% effective dose (ED90) of phenylephrine for hypotension during elective cesarean delivery using a continual reassessment method.
The purpose of this study was to determine, by continual reassessment, the 90% effective dose (ED90) of phenylephrine for hypotension after combined spinal-epidural anesthesia. ⋯ The ED90 of a phenylephrine bolus dose for hypotension in term pregnant women is approximately 100μg, based on continual reassessment.
-
Eur. J. Obstet. Gynecol. Reprod. Biol. · Oct 2015
Practice GuidelineFetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
Small for gestational age (SGA) is defined by weight (in utero estimated fetal weight or birth weight) below the 10th percentile (professional consensus). Severe SGA is SGA below the third percentile (professional consensus). Fetal growth restriction (FGR) or intra-uterine growth restriction (IUGR) usually correspond with SGA associated with evidence indicating abnormal growth (with or without abnormal uterine and/or umbilical Doppler): arrest of growth or a shift in its rate measured longitudinally (at least two measurements, 3 weeks apart) (professional consensus). ⋯ Testing for antiphospholipids (anticardiolipin, circulating anticoagulant, anti-beta2-GP1) is recommended in women with previous severe FGR (below third percentile) that led to birth before 34 weeks of gestation (professional consensus). It is recommended that aspirin should be prescribed to women with a history of pre-eclampsia before 34 weeks of gestation, and/or FGR below the fifth percentile with a probable vascular origin (professional consensus). Aspirin must be taken in the evening or at least 8h after awakening (Grade B), before 16 weeks of gestation, at a dose of 100-160mg/day (Grade A).
-
Eur. J. Obstet. Gynecol. Reprod. Biol. · Oct 2015
Multicenter StudyThe pelvic floor muscle hyperalgesia (PFMH) scoring system: a new classification tool to assess women with chronic pelvic pain: multicentre pilot study of validity and reliability.
The contribution of pelvic floor muscle tenderness to chronic pelvic pain (CPP) is well established in the literature. However pelvic floor muscle hyperalgesia (PFMH) is often missed during vaginal examination of women with CPP. To our knowledge criteria for diagnosing PFMH has not been established or validated so far. The aim of this study is to assess the validity and reliability of the PFMH scoring system. ⋯ The PFMH scoring system is a simple, reliable, valid and easy screening tool for in the assessment of women with CPP.